Article
Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment.
Journal of neurochemistry - 1 Nov 2009
Klein Christian L, Rovelli Giorgio, Springer Wolfdieter, Schall Christoph, Gasser Thomas, Kahle Philipp J
Abstract excerpt
Mutations in the gene encoding leucine-rich repeat kinase 2 (LRRK2) are the most common cause of autosomal-dominant familial and late-onset sporadic Parkinson's disease (PD). LRRK2 is a large multi-domain protein featuring a GTP-binding C-terminal of Ras of complex proteins (ROC) (ROCO) domain combination unique for the ROCO protein family, directly followed by a kinase domain. Dimerization is a well-established...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
